QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

SANA

QT67Sana Biotechnology, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
3.15
+0.11+3.62%
OverviewShort InterestFilings
SANAQT67Sana Biotechnology, Inc.·NASDAQ
OverviewShort InterestFilings
3.15+3.62%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own31.30%
Shs Outstand278.29M
Perf Week13.72%
Market Cap846.01MForward P/E-EPS next Y-0.58Insider Trans0.08%Shs Float-Perf Month2.94%
Enterprise Value837.53MPEG0.34EPS next Q-0.15Inst Own-Short Float-Perf Quarter-0.63%
Income-243226850.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y-37.00%
Sales-P/B7.06EPS next Y5.75%ROA-64.77%Short Interest-Perf YTD-22.60%
Book/sh0.43P/C-EPS next 5Y-ROE-161.87%52W High6.55 -51.91%Perf Year12.10%
Cash/sh0.36P/FCF-EPS past 3/5Y-ROIC-78.61%52W Low2.58 22.09%Perf 3Y-
Dividend Est.-EV/EBITDA-4.48Sales past 3/5Y-Gross Margin0.00%Volatility4.88% 4.64%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM47.41%Oper. Margin0.00%ATR (14)0.22Perf 10Y-
Dividend Ex-Date-Quick Ratio1.29Sales Y/Y TTM-Profit Margin0.00%RSI (14)54.91Recom2.00
Dividend Gr. 3/5Y-Current Ratio1.29EPS Q/Q30.00%SMA205.67%Beta2.75Target Price8.67
Payout0.00%Debt/Eq0.63Sales Q/Q-SMA50-1.75%Rel Volume1.66Prev Close3.04
Employees194LT Debt/Eq0.40EarningsAug 10SMA200-17.86%Avg Volume4.07MPrice3.15
IPO DateFeb 04, 2021Option/ShortYes / YesEPS/Sales Surpr.6.67% -Net Debt/EBITDA0.05Volume6,743,361Change3.62%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-14-26ReiteratedWedbushOutperform$7.00
Mar-13-26ReiteratedMorgan StanleyOverweight$12
Mar-04-26ReiteratedH.C. Wainwright$8.00 → $7.00
Oct-30-25ReiteratedJMP SecuritiesMarket Outperform$5.00 → $8.00
Mar-18-25UpgradeCitizens Capital MarketsMarket Perform → Market Outperform
Jan-08-25UpgradeTD CowenHold → Buy
Nov-05-24ReiteratedH.C. Wainwright$12 → $8.00
Nov-05-24DowngradeJMP SecuritiesMarket Outperform → Market Perform
Jan-16-24ReiteratedH.C. Wainwright$12
Jan-16-24UpgradeHC Wainwright & Co.Neutral → Buy
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1300
Gross Profit-1300
Selling, General and Administrative Excl. Other446473
Research and Development132209220
Other Operating Expense200
Operating Income-191-273-293
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)53-6-10
Net Income Before Taxes-244-267-283
Income Taxes000
Consolidated Net Income-244-267-283
Net Income From Continuing Operations-244-267-283
Net Income-244-267-283
EPS (Recurring)-0.96-1.16-1.46
EPS (Basic, Before Extraordinaries)-0.96-1.16-1.46
EPS (Diluted)-0.96-1.16-1.46
EBITDA-231-249-259
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding253231195
Market Capitalization1,030——
Operating Lease Expense
———
Insider Trading Volume
$3.73$3.47$3.21$2.96$2.70● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Harr StevePresident & CEOMar 07 '26Option Exercise0.00100,00007,968,596Mar 10 12:00 AM
Wyrick Susan D.See RemarksMar 07 '26Option Exercise0.006,5000200,583Mar 10 12:00 AM
Harr StevePresident & CEOMar 06 '26Option Exercise0.0083,33207,918,596Mar 10 12:00 AM
Wyrick Susan D.See RemarksMar 06 '26Option Exercise0.0020,8320197,333Mar 10 12:00 AM
Wyrick Susan D.See RemarksMar 02 '26Option Exercise0.003,0500187,408Mar 04 12:00 AM
Wyrick Susan D.See RemarksJan 02 '26Option Exercise0.0015,0000188,290Jan 06 12:00 AM
Wyrick Susan D.See RemarksDec 13 '25Option Exercise0.006,8000181,663Dec 16 12:00 AM
Wyrick Susan D.See RemarksDec 03 '25Option Exercise0.0020,0000180,828Dec 05 12:00 AM
Wyrick Susan D.See RemarksJun 03 '25Option Exercise0.0020,0000170,395Dec 05 12:00 AM
Cassidy Bernard JEVP & General CounselMar 07 '25Option Exercise0.0022,0820115,823Mar 10 12:00 AM
Harr StevePresident & CEOMar 07 '25Option Exercise0.00100,00007,889,750Mar 10 12:00 AM
Wyrick Susan D.See RemarksMar 07 '25Option Exercise0.006,5000158,231Mar 10 12:00 AM
Wyrick Susan D.See RemarksMar 02 '25Option Exercise0.003,0500155,471Mar 03 12:00 AM
FMR LLC10 percent owner, other: See Remark 1Jan 08 '25Sale6.49290,9121,887,3204,541,511Jan 10 12:00 AM
Wyrick Susan D.See RemarksJan 02 '25Option Exercise0.0010,0000155,512Jan 03 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR